Effectiveness of Metformin and Lifestyle Interventions as Initial Treatment in Japanese Patients with Type 2 Diabetes (EMINENT Study)

Effectiveness of Metformin and Lifestyle Interventions as Initial Treatment in Japanese Patients with Type 2 Diabetes (EMINENT Study) - Effectiveness of Metformin and Lifestyle Interventions as Initial Treatment in Japanese Patients with Type 2 Diabetes (EMINENT Study)

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000004193

Enrollment

Registered

2010-09-22

Start date

2010-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Newly diagnosed patients with type 2 diabetes aged 20 years and older.

Exclusion criteria

Exclusion criteria: Type 1 diabetes. Patients contraindicated to metformin. Patients judged not to be eligible by the principal investigator.

Design outcomes

Primary

Measure	Time frame
Change in glycated hemoglobin (HbA1c) at 16 weeks after the initiation of the treatment	—

Secondary

Measure	Time frame
Change in body weight, fasting plasma glucose, glycated albumin, total cholesterol, triglyceride, HDL-cholesterol, liver enzymes, and an incidence of adverse effects during treatment.	—

Countries

Japan

Contacts

Public ContactSatoru Sumitani

Nissay Hospital Center for Preventive Medicine

sa_sumitani@yahoo.co.jp06-6543-3581

Outcome results